by John A. Jenkins | May 8, 2025 | FDA, FOIA, FTC, News Media, SEC
The Latest Requests Logged in FOIAengine Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s regulatory nominees are among those in newly available Freedom of Information Act requests filed by media organizations with the...
by Randy E. Miller | Nov 20, 2024 | FOIA, FTC, News Media
FOIAengine: News Media Seeks Records from Consumer Sentinel Network New research from PoliScio Analytics demonstrates how journalists use Freedom of Information Act requests to the Federal Trade Commission to uncover bad news about companies and individuals. The FTC...
by John A. Jenkins | Sep 11, 2024 | FDA, FOIA, FTC, SEC
FOIAengine Explores the Widespread Use of “Neither Confirm Nor Deny” By John A. Jenkins We’re taking a look this week at a frequently used Freedom of Information Act exemption that isn’t mentioned anywhere in the statutory language. It’s known as “Glomar” among the...
by Randy E. Miller | Aug 21, 2024 | Antitrust, Cryptocurrency, FOIA, FTC, News Media
FOIAengine Analysis Reveals Targets and Topics News media outlets continued to be the leading submitters of Freedom of Information Act requests to the Federal Trade Commission during the first half of 2024, with many of the requests focused on the agency’s...
by John A. Jenkins | Jul 30, 2024 | Antitrust, FOIA, FTC, Law Firms, Pharmaceuticals
FOIA Requests Target Scott Sheffield, King of the Frackers, Amid Reports of a Criminal Referral This week, we’re looking into how antitrust enforcers used their approval of an oil-industry megadeal to send a message about white-collar criminality. It’s a cautionary...
by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals
FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
